Klinik für Innere Medizin II Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.
Klinik für HNO-Erkrankungen Kopf-Hals-Chirurgie, Interdisziplinäre Palliativstation Südharz Klinikum Nordhausen, Dr.-Robert-Koch-Straße 39, 99734, Nordhausen, Germany.
BMC Med Inform Decis Mak. 2023 Aug 18;23(1):161. doi: 10.1186/s12911-023-02259-4.
Previous studies have already shown that decision aids are a suitable tool for patient decision-making. The aim of this work is to conduct an online search for freely available, German-language patient decision aids (PDAs) for cancer patients, followed by an assessment of their quality. For this purpose, a rating tool that is as manageable as possible was developed on the basis of already existing quality criteria.
A simulated patient online search was conducted via the four most frequently used search engines in Germany. A quality assessment tool was created utilizing international and national guidelines, with a focus on practicality and manageability. Subsequently, the identified PDAs were rated by 4 raters based on the rating tool.
The number of German-language oncology PDAs is low (n = 22 of 200 URLs) with limited variability regarding rare cancers. Most originate from non-profit organizations. The overall quality is low, as indicated by an average of 57.52% of the maximum evaluation points of the developed quality assessment tool. Reference values used to assess quality were related to e.g. support/effectiveness, adaptation, layout, etc. No qualitative differences were found regarding different publishers. Quality differed between PDAs of different length, with longer PDAs achieving better results.
Overall, the supply and quality of German-language PDAs is not satisfactory. The assessment tool created in this study provides a solid, but more manageable basis, for developing and identifying high-quality PDAs.
PDAs should be increasingly used by physicians in practice. For this, a quick qualitative assessment of PDAs in everyday life must be possible. Future research has to investigate especially the aspect of the length of a PDA in more detail.
之前的研究已经表明,决策辅助工具是患者决策的合适工具。本研究的目的是在线搜索免费的、德语的癌症患者决策辅助工具(PDAs),并对其质量进行评估。为此,在已有质量标准的基础上,开发了一种尽可能易于管理的评分工具。
通过德国使用最频繁的四个搜索引擎进行模拟患者在线搜索。利用国际和国家指南创建了一个质量评估工具,重点是实用性和可管理性。随后,由 4 名评估者根据评分工具对确定的 PDAs 进行评分。
德语肿瘤学 PDAs 的数量较少(200 个 URL 中有 22 个),罕见癌症的多样性有限。大多数来自非营利组织。总体质量较低,开发的质量评估工具的最高评估点平均为 57.52%。用于评估质量的参考值与支持/有效性、适应性、布局等有关。不同出版商之间没有发现定性差异。质量因 PDA 的长度不同而有所差异,较长的 PDA 效果更好。
总体而言,德语 PDAs 的供应和质量不尽如人意。本研究创建的评估工具为开发和识别高质量 PDAs 提供了一个坚实但更易于管理的基础。
医生应在实践中越来越多地使用 PDAs。为此,必须能够在日常生活中快速对 PDAs 进行定性评估。未来的研究必须更详细地研究 PDA 长度的方面。